期刊文献+

PEG可脱除材料修饰miRNA纳米粒的制备以及体内外性质的考察 被引量:1

Preparation of sheddable PEG modified miR NA-complexing nanoparticles and its preliminary in vitro and in vivo study
下载PDF
导出
摘要 制备PEG可脱除材料修饰miR NA纳米粒,考察其细胞摄取以及体内分布情况。采用酰胺键缩合的方法合成可被β-环糊精包合的金刚烷修饰的PEG材料,通过静电作用与miR-34a复合制得纳米粒,加入与β-环糊精亲和力更高的布洛芬后可置换脱除纳米粒的PEG壳,测定该PEG可脱除纳米粒的粒径和Zeta电位;考察其在4T1细胞上的摄取能力以及在荷有4T1细胞的BALB/c小鼠体内的分布情况。结果显示,可被β-环糊精包合的金刚烷修饰的PEG材料合成成功;通过静电作用与miR-34a复合后制得的PEG可脱除纳米粒,粒径为107.7 nm,Zeta电位为15.8 mV;相比于PEG未脱除的纳米粒,被4T1细胞摄取的能力与在小鼠体内肿瘤部位的浓度都有显著提高,该体系在肿瘤治疗领域的应用具有很大的潜力。 This study was aimed to prepare sheddable PEG modified miRNA-complexing nanoparticles and investigate in vitro cellular uptake effect and in vivo distribution profile. The sheddable PEG material was synthe- sized through condensation. The sheddable PEG modified miRNA-complexing nanoparticles were successfully prepared by electrostatic interaction between gene vector and miRNA, and then ibuprofen was added to deshield PEG layer. The in vitro cellular uptake effect and in vivo distribution profile of nanoparticles were investigated on 4T1 model cells. As a result, the particle size of nanoparticles was 107.7 nm and Zeta potential was 15.8 mV. Compared to unsheddable PEG group, the cellular uptake effect by 4T1 tumor cells as well as the concentration on tumor regions was significantly improved in the sheddable PEG group. Results showed that this systen has a great potential application in the field of tumor treatment.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2016年第6期702-707,共6页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.81422044)~~
关键词 PEG可脱除 基因载体 纳米粒 MIR-34A 4T1细胞 乳腺癌 sheddable PEG gene vector nanoparticles MiR-34a 4T1 cells breast cancer
  • 相关文献

参考文献2

二级参考文献19

  • 1OgrisM, Steinlein P, KursaM. The size of DNA /transferrin-PEI complexes is an important factor for gene expression in cultured cells[J]. Gene Ther,1998,5(10) :1 425 - 1 433.
  • 2Verma IM, Somia N. Gene therapy promises, problems and prospects[J]. Nature ,1997 ,389(6 648) :239 -242.
  • 3Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine [ J ]. Proc Natl Acad Sci USA, 1995,92 ( 16 ) : 7 297-7 301.
  • 4Pack DW, Hoffman AS, Pun S, et al. Design and development of polymers for gene delivery[ J]. Nat Rev Drug Discov,2005,4(7) : 581 - 593.
  • 5Kunath K, yon Harpe A, Fischer D, et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery:comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine [ J ]. J Control Release,2003,89 ( 1 ) : 113 - 125.
  • 6Sharma VK,Thomas M ,Klibanov AM. Mechanistic studies on aggregation of polyethylenimine-DNA complexes and its prevention [ J ]. Biotechnol Bioeng,2005,90 (5) :614 - 620.
  • 7Choosakoonkriang S,Lobo BA, Koe GS,et al. Biophysical characterization of PEI/DNA complexes [ J ]. J Pharm Sci ,2003,92 ( 8 ) : 1710-1 722.
  • 8Zanta MA, Boussif O, Adib A,et al. In vitro gene delivery to hepatocytes with galacto-sylated polyethylenimine [ J ]. Bioconjug Chem, 1997,8(6) :839 - 844.
  • 9Lemkine GF, Demeneix BA. Polyethylenimines for in vivo gene delivery[J]. Curr Opin Mol Ther,2001,3( 2 ):178 -182.
  • 10Fisher KD, Ulbrich K, Subr V ,et al. A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression [ J ]. Gene Ther, 2000,7 ( 15 ) : 1 337 - 1 343.

共引文献2

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部